Evidence map›Paper›PMID 34501583›Full record

ArticleInternational journal of environmental research and public health2021

COVID-19 Screening by Anti-SARS-CoV-2 Antibody Seropositivity: Clinical and Epidemiological Characteristics, Comorbidities, and Food Intake Quality.

Gabriela Macedo-Ojeda, José Francisco Muñoz-Valle, Patricia Yokogawa-Teraoka, Andrea Carolina Machado-Sulbarán, María Guadalupe Loza-Rojas, Atziri Citlally García-Arredondo, Rafael Tejeda-Constantini, Alejandra Natali Vega-Magaña, Guillermo González-Estevez, Mariel García-Chagollán and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gabriela Macedo-OjedaInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
José Francisco Muñoz-ValleInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0002-2272-9260
Patricia Yokogawa-TeraokaCOVID-19 Health Situation Room, University of Guadalajara, Guadalajara 44100, Mexico.
Andrea Carolina Machado-SulbaránInstitute for Research in Childhood and Adolescent Cancer (INICIA), University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0001-7879-9316
María Guadalupe Loza-RojasDepartment of Applied Clinical Nursing, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
Atziri Citlally García-ArredondoDepartment of Applied Clinical Nursing, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
Rafael Tejeda-ConstantiniInstitutional System of Safety, Health and Environment (SISSMA), University of Guadalajara, Guadalajara 44100, Mexico.
Alejandra Natali Vega-MagañaInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
Guillermo González-EstevezInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
Mariel García-ChagollánInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.
José Sergio Zepeda-NuñoDepartment of Microbiology and Pathology, Pathology Laboratory, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0002-1804-6061
Jorge Hernández-BelloInstitute of Research in Biomedical Sciences, University Center for Health Sciences (CUCS), University of Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0001-8004-1811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing countries have reported lower molecular diagnostic testing levels due to a lack of resources. Therefore, antibody tests represent an alternative to detect exposure to SARS-CoV-2 and analyze possible risk factors. We aimed to describe and compare the clinical-epidemiological characteristics and the quality of food intake in Mexican individuals with a positive or negative test to antibodies against SARS-CoV-2. We carried out antibody tests and applied a survey to 1799 individuals; 42% were positive, and diabetes was more prevalent in these cases (

Indexed as

COVID-19Antibodies, ViralComorbidityEatingHumansMass ScreeningSARS-CoV-2Antibodies, Viralclinical characteristicsCOVID-19food intake qualityserological testing

Identifiers

PMID34501583
PMCPMC8431502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.